Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

Description

A comparison of two anesthetic techniques for total knee replacements: (1) Peri-Articular Injection (PAI), local infiltration between the popliteal artery and capsule of the knee block (IPACK) and single-shot adductor canal block (ACB) vs. (2) PAI, IPACK and continuous adductor canal block catheter (ACC).

Conditions

Anesthesia

Study Overview

Study Details

Study overview

A comparison of two anesthetic techniques for total knee replacements: (1) Peri-Articular Injection (PAI), local infiltration between the popliteal artery and capsule of the knee block (IPACK) and single-shot adductor canal block (ACB) vs. (2) PAI, IPACK and continuous adductor canal block catheter (ACC).

Expanding the Peri-operative Surgical Home Model: ERAS TKR With a Transitional Pain Service (TeleTPS)- Continuous Adductor Canal Catheter Versus Adductor Canal Block for Total Knee Arthroplasty, a Randomized Double-blind Controlled Trial

Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

Condition
Anesthesia
Intervention / Treatment

-

Contacts and Locations

New York

Hospital for Special Surgery, New York, New York, United States, 10023

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients with osteoarthritis scheduled for a primary total knee arthroplasty with a participating surgeon
  • * Planned use of regional anesthesia
  • * Ability to follow study protocol
  • * English speaking (secondary outcomes include questionnaires validated in English only)
  • * Lives within one hour of the hospital
  • * Has a smart phone
  • * Hepatic or renal insufficiency
  • * Younger than 18 years old or older than 65 years ol
  • * Patients undergoing general anesthesia
  • * Allergy or intolerance to one of the study medications
  • * BMI \>40
  • * Diabetes
  • * American Society of Anesthesiologists (ASA) status III or IV
  • * Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
  • * Patients with chronic pain (from a referral to chronic pain service) or a pain catastrophizing scale (PCS \>30)
  • * Patients with severe valgus deformity or flexion contracture
  • * Patients unable to follow home catheter instructions and unwilling to go home with an infusing catheter
  • * Patients who have no home caregivers in the event that a catheter is to be sent home with the patient
  • * Patients with planned stay at rehab facility (to avoid medical device being tampered with at the rehab facility)
  • * Non-English speakers (secondary outcomes include questionnaires validated in English only)

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Hospital for Special Surgery, New York,

David Kim, MD, PRINCIPAL_INVESTIGATOR, Hospital for Special Surgery, New York

Study Record Dates

2025-12